- EUR/USD:1.2164+0.0027+0.23%
- Natural Gas:2.6405+0.0435+1.65%
- Gold:1,849.74-6.2500-0.34%
- GBP/JPY:142.46+0.6250+0.44%
- Bitcoin:31,610-24.250-0.08%
- WTI Oil:52.913+0.1030+0.19%
- S&P 500:3,849.62-5.7400-0.15%
- AUD/USD:0.7742+0.0040+0.51%
- Ethereum:1,291.00-25.890-2.01%
- Silver:25.431+0.0898+0.35%
- USD/CAD:1.2712-0.0036-0.28%
- XRP:0.2625-0.0035-1.33%
- EUR/USD:1.2164+0.0027+0.23%
- Natural Gas:2.6405+0.0435+1.65%
- Gold:1,849.74-6.2500-0.34%
- GBP/JPY:142.46+0.6250+0.44%
- Bitcoin:31,610-24.250-0.08%
- WTI Oil:52.913+0.1030+0.19%
- S&P 500:3,849.62-5.7400-0.15%
- AUD/USD:0.7742+0.0040+0.51%
- Ethereum:1,291.00-25.890-2.01%
- Silver:25.431+0.0898+0.35%
- USD/CAD:1.2712-0.0036-0.28%
- XRP:0.2625-0.0035-1.33%
Opinions
- Brexit Update – As the Weekend Nears, so does sub-$1.30 Levels for the Pound…
A no-deal scenario the likely outcome. That’s the news of the day. The ever eternal optimists will be hoping for good news before the markets close…
- COVID-19 Vaccine Update – It’s All Eyes on the FDA and BioNTech/Pfizer Inc.
The FDA is due to review BioNTech/Pfizer Inc.’s vaccine later today. Approval is a must to support riskier assets and give some hope to the worst affected.
- Brexit – Gaps Remain with a Sunday Deadline Now Looming
The British PM and EU President agree to a Sunday deadline. Make or break talks will now continue and the Pound could come under fire…
- Brexit – Hope Returns as Boris Heads for Brussels
It’s all eyes on Brussels, with British PM Johnson looking to salvage a Brexit deal. A failure to agree on a way forward would sink the Pound.
- Brexit – Hope Turns to Despair, Sinking the Pound
The Pound slides back to $1.32 levels off the back of gloomy Brexit updates. Pound sensitivity will be on the rise as time now rapidly runs out.
- COVID-19 Vaccine Update – It is all Eyes on UK Vaccinations and the FDA This Week
With the UK set to begin vaccinations this week and the FDA to review the Pfizer Inc. vaccine, production and logistics news will be of particular interest.
- Brexit – Can the never Ending List of Demands Bring the Curtain Down?
Are we in for one more Brexit shock?
- COVID-19 Vaccine Update – The UK Wastes No Time as MHRA Approves Vaccine
The UK becomes the first nation to approve a COVID-19 vaccine and with an efficacy rate of 95%, an end to the pandemic may be in sight.
- Brexit Update – Talks Continue as EU Member States Keep an Eye on Barnier
Time is running out and yet both sides stand firm on the remaining hurdles. The markets and the Pound continue to reflect optimism, however.
- COVID-19 Vaccine Update – Moderna Inc. Requests Approval from the FDA and the EMA
Moderna Inc. submits its EUA to the FDA, with both Pfizer Inc. and Moderna Inc. also submitting requests to the EMA.
- COVID-19 Vaccine Update – Focus Shifts to Pre-orders and Distribution
AstraZeneca last week announced plans to launch a new global trial. Without the AstraZeneca vaccine, however, many nations will be without…
- Stocks Look Ready To Test New Highs Amid Vaccine Optimism And Stimulus Hopes
There is some rotation from tech stocks into cyclical stocks.
- COVID-19 Vaccine Update – AstraZeneca Leaves the Door Ajar for Other Pharmas
As more details emerge from AstraZeneca’s clinical trials, the door may be ajar for another U.S pharma to make a move.
- Brexit – A New President Who Just Doesn’t Think Like Donald
As Brexit talks get set to resume, Boris may be feeling hot under the collar. A message from Biden and a warning from the EU. Compromise or else…
- Brexit – Mixed Signals and Anger on the British Side of the Channel
Face to face talks are set to resume with Barnier coming out of self-isolation. The two sides at odds, however, with time running out.
- COVID-19 Vaccine Update – AstraZeneca Releases Trial Results
AstraZeneca and the University of Oxford fail to impress the markets with phase 3 trial results. Logistics and production could favor their vaccine, however.
- COVID-19 Vaccine Update – Pfizer Inc. Submits an EUA
Pfizer Inc. and BioNTech submit a EUA. Moderna Inc. and AstraZeneca need to catch up…
- Brexit – Talks Hit Pause, with Calls for an Extension Beginning to Surface
Brexit talks hit pause as EU negotiators self-isolate. With the transition period ending in just over a month, is an extension around the corner?
- COVID-19 Vaccine Update – The Numbers are Impressive but the Markets Need More
Pfizer Inc. addresses safety concerns and virus efficacy amongst the elderly. Is it enough for the FDA to approve and for manufacturing to commence?
- Brexit – Politics is a Game and Neither Side Wants to Concede
The proverbial can continues to get kicked down the road. Brexit talks continue and the EU Summit on Thursday may not be the end of it.
Most Popular
Trade With A Regulated Broker
- Your capital is at risk